>
Organization
Bioverativ Therapeutics, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Bioverativ Therapeutics, Inc.

... 2018 (GLOBE NEWSWIRE) -- Amunix Operating Inc. is pleased to report that Bioverativ (a Sanofi company) has announced preliminary Phase 1/2a safety and pharmacokinetic clinical ...
... is trumpeting new clinical data for a hemophilia A drug developed by Bioverativ that it contends could transform treatment of the bleeding disorder. The phase ...
... Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi Commences Tender Offer for Acquisition of Bioverativ Inc. Paris - February 8, 2018 - Sanofi announced today that on ...
... approved and marketed as ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] by Bioverativ in the United States, Japan and Canada. It is also approved in ...
... transformation. Right before announcing its $11.6 billion deal for Biogen’s hemophilia spinout Bioverativ, Sanofi promoted Dominique Carouge, who has been with the company since 1991, ...
... therapies. The study is being performed under the collaboration agreement with Bioverativ Therapeutics Inc. The development of antibodies (inhibitors) that neutralise the effect of factor ...
... Bioverativ has announced that the FDA has accepted the company's Investigational New Drug ...
... sales for our hemophilia products, ELOCTATE and ALPROLIX, as the spin-off of Bioverativ is expected to complete on February 1, 2017.GAAP guidance includes the minimum ...
... is part of Biogen's hemophilia business, which is expected to launch as Bioverativ on February 1, 2017 as an independent, public company focused on the ...
... will be live on Thursday, January 5, 2017 at 4:00p.m. ET. Additionally, Bioverativ, the planned spin-off of Biogen's hemophilia business, will present as well. That ...
Subscribe now for full coverage on Bioverativ Therapeutics, Inc.
Start My Free Trial